ClinicalTrials.Veeva

Menu
H

Hospital da Luz | Lisboa

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

9-ING-41
Azacitidine
Ontamalimab
Ribociclib
Magrolimab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 7 total trials

9-ING-41 in Patients With Advanced Cancers

GSK-3β is a potentially important therapeutic target in human malignancies. The Actuate 1801 Phase 1/2 study is designed to evaluate the safety and e...

Active, not recruiting
Neoplasm of Lung
Neoplasms Pancreatic
Drug: Gemcitabine - 21 day cycle
Drug: 9-ING-41

The ICONIC-M study is a multicenter randomized controlled study to assess patient response to CRT comparing ECGI map guided left ventricular lead pla...

Enrolling
Heart Failure With Reduced Ejection Fraction
Device: Pre-implantation planning
Device: Post-implantation assessment

This is an open-label, multicenter international trial in men and women with primary operable HR+/HER2-, ki67≥20%, grade 2 or 3 and stage II breast c...

Enrolling
Breast Cancer Stage II
Drug: Ribociclib (adjuvant)
Drug: Chemotherapy (adjuvant)

Trial sponsors

Shire logo
A
E
Gilead Sciences logo
S
F

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems